VTE Flashcards

1
Q

Prevalence of PE in pregnancy?

A

2-6%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

At what stage (ante/intra/postpartum) is the risk of a VTE highest?

A

Postpartum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the symptoms of a DVT and PE?

A

DVT - leg swelling, tenderness, erythema, pain, lower abdominal pain ( if extension into pelvic vessels)

PE - dyspnoea, chest pain,
haemoptysis and collapse

Low grade pyrexia and leucocytosis can alconoccur with both

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How do u diagnosis acute DVT?

A

Compression lower limb duplex ultrasound

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What percentage of patients with untreated DVT will develop PE?

A

15-24%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

In what percentage of pregnant patients is PE fatal?

A

15%

  • of these 66% will die within 30mins of embolic event
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the sensitivity and negative predictive value of serial compression ultrasonography in detecting DVT?

A

Sensitivity - 94.1%
Negative Predictive Value- 99.5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How do u diagnosis an acute PE?

A
  • Computerized Tomography Pulmonary Angiogram
    • more readily available than V/Q, shows other lung pathology
    • low radiation to fetus, relatively high dose to maternal breast tissue (20mGy) = increased risk breast ca
    • bismuth Shields over breast decrease risk by 20-40%
  • Ventilation/Perfusion lung scan
    • neg predictive value of 99%
    • slight increased risk of childhood cancers

If CTPA not available:
- Cxray: normal in 50%, features of PE include atelectasis, effusion, focal opacity, pulmonary oedema (kurly b lines - indicate thickened, oedematous interlobular septa)
- helps to exclude lung infection, pneumothorax and lobar collapse.
*negligible radiation dose <0.01mSv

ECG is of limited diagnostic value and is abnormal in 41% of pts with PE.
- most common abnormalities: T wave inversion, S1Q3T3 pattern and Rt bundle branch block.
- Also helps to exclude other causes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

T/F. Tranexamic acid is assoc with an increased risk of VTE?

A

False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How many current risk factors (other than prev VTE or Thrombophilia) are required for thromboprophylaxis/lmwh throughout the antenatal period?

A

4 or more

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How many current risk factors (other than prev VTE or Thrombophilia) are required for thromboprophylaxis/lmwh from 28 weeks gestation?

A

3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Patient has 2 current risk factors for VTE (other than prev VTE or Thrombophilia). What’s your advice ?

A

CONSIDER prophylactic LMWH for at least 10 days postpartum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

T/F. All women requiring antenatal prophylactic LMWH should continue prophylaxis for 6 weeks postnatally?

A

True - usually this is true, however a postnatal assessment should always be made.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How should a pt with a single previous VTE (not related to a major surgery) be managed?

A

-Prepregnancy counselling
-Management plan for VTE in pregnancy should be made
- should be offered thromboprophylaxis with LMWH throughout antenatal period.

If pregnant refer to an expert in thrombosis in pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Management of a pt with a previous thrombophilia-asscoiated VTE?

A

Thrombophilias may be HERITABLE or ACQUIRED.

For VTEs due to Antithrombin deficiency a Multi-disciplinary team approach is needed.

  • MFM specialist with collaboration with a haematologist with expertise w/ thrombosis in pregnancy.
    – consider antenatal anti-Xa monitoring
    — consider potential need for antithrombin replacement at START of labour or PRIOR to csection.
  • Offer thromboprophylaxis with higher dose LMWH (either 50%, 75% or full therapeutic dose) antenatal and for 6 weeks postpartum OR until returned to oral anticoagulant therapy post delivery.
    — as most pts would have been managed on oral anticoagulation.

For other heritable thrombophilic defects can be managed with standard doses of thromboprophylaxis as they are lower risk.

ACQUIRED thrombophilia
- Pts with Antiphospholipid syndrome/APS are usu on long term anticoagulation.
- manage with haematologist and rheumatologist w/ expertise in this area.
- Offer thromboprophylaxis with higher dose LMWH (either 50%, 75% or full therapeutic dose) antenatal and for 6 weeks postpartum OR until returned to oral anticoagulant therapy post delivery.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Management of a pt with a previous recurrent VTE?

A
  • MDT; seek advice re dose of anticoagulant by a haematologist
  • higher doses of LMWH required
  • Patients on long term wafarin or other anticoagulants should be counselled about the risks to the fetus.
  • should stop oral anticoagulant and switch to LMWH as soon as pregnancy is confirmed - ideally before GA 6 weeks.
  • Women NOT on oral anticoagulants should start LMWH as soon as she has a positive pregnancy test.
17
Q

Advice for a pregnant women with a h/o a prior VTE that was unprovoked/ due to a transient/oestrogen related (OCPs/pregnancy) risk factor?

A

Prophylaxis with LMWH throughout the antenatal period.

  • if it was unrpovoked, we don’t know what caused it so better safe than sorry. She’s pregnant again, so if it was oestrogen related before it can occur again
18
Q

Advice for a pregnant woman with a h/o a VTE due to major surgery. She had recovered and has no other risk factors.

A

Start LMWH at 28 weeks if no other risk factors are identified.
– monitor for development of other risk factors

  • Other risk factors found? Give throughout antenatal period.
19
Q

What are the pre-existing risk factors for VTE in pregnancy and the puerperium?

A

There are 9:
1. Previous VTE
2. Thrombophilia
3. >35yrs
4. Medical comorbidities [active SLE, cancer, heart failure, IBD, inflamm polyarthropathy, T1DM w/nephropathy, sickle cell, current iv drug user]
5. Obesity BMI>30
6. Parity 3/more
7. Smoking
8. Gross varicose veins
9. Paraplegic

20
Q

What are the obstetric risk factors for VTE in pregnancy and the puerperium?

A

There are 8:
1. Multiple pregnancy
2. Current preeclampsia
3. Prolonged labour >24hrs
4. Mid-cavity or rotational operative delivery
5. Preterm birth
6. Stillbirth
7. C-section
8. PPH >1L/requiring transfusion

21
Q

What are the new onset/transient risk factors for VTE in pregnancy and the puerperium?

A

There are 7:
1. Ovarian hyperstimulation
2. Hyperemesis, dehydration
3. Long-distance travel >4hrs
4. Admission/Immobility 3/more days
5. Current systemic infection (requiring admission/ iv antibiotics)
6. Any surgical procedure in pregnancy/puerperium
–perineal repair excluded
7. Bone fracture

22
Q

30 wks, 12hr flight to UK, with chest pain and dyspnoea. Booking wt 66kd, current wt 76kg. What dose of:
1. enoxaprin
2. dalteparin

A

Booking wt 66kg, therefore in second wt class [50-69kg] for both drugs.
■Enox:
▪︎60mg sc bd (first class is 40mg bd & increases by 20 to 120mg bd)
▪︎90mg sc od (60 +30; remember od increments [20, 30, 40, 50, 60] are added to the bd dose to get the od dose)
▪︎▪︎Doses >120mg = haematologist

■Dalteparin
Od Doses are double the bd Doses
66kg = 6,000iu bd or 12,000iu od

Remember bd dosing starts at 5,000iu and stops at 12,000iu. >12,000 = Haematologist

23
Q

Pt with PE at 38 weeks. Received bolus dose and on 18mg/kg/hr unfractionated heparin. APTT ratio 6hrs after bolus dose is 1.3. Next step?

A

40units/kg bolus + 20units/kg/hr infusion.

Why 20 units?
▪︎18+2=20units

If APTT:
▪︎ <1.2: Add 4 units
(18+4=22units/kg/hr)
1.2-1.5: add 2 units = 20 units
1.5-2.5: no change
2.5-3.0: minus 2 units (18-2=16u)
>3.0: minus 3 units (18-3=15units)

24
Q

What is the target APTT ratio when on unfractionated heparin infusion?

A

1.5-2.5 times lab control value

25
Q

How often is APTT measured when on unfractionated therapy?

A
  1. 4-6hrs after loading dose
  2. 6 hours after any dose adjustment
  3. Daily once in therapeutic range
26
Q

Incidence of VTE in pregnancy and puerperium?

A

1-2/1000 (0.1-0.2%)